Another possible option could be the use of the epigenetic drugs, the HDAC inhibitors vorinostat (Zolinza) and/or valproic acid alone or in combination that has been shown to increase PMCA4b expression in a variety of melanoma and breast cancer tumor cells including A375 and MCF-7 [28,29,75]. This evidence concerns the gene HDAC9 and breast carcinoma.